NASDAQ:ICUI ICU Medical - ICUI Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding ICU Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $161.51 +3.98 (+2.53%) (As of 03/20/2023 12:00 AM ET) Add Compare Share Share Today's Range$157.73▼$161.7950-Day Range$153.15▼$198.2152-Week Range$128.90▼$249.40Volume130,951 shsAverage Volume190,146 shsMarket Capitalization$3.88 billionP/E RatioN/ADividend YieldN/APrice Target$195.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability ICU Medical MarketRank™ ForecastAnalyst RatingModerate Buy2.50 Rating ScoreUpside/Downside20.7% Upside$195.00 Price TargetShort InterestN/ADividend StrengthN/ASustainability-1.47Upright™ Environmental ScoreNews SentimentN/AInsider TradingSelling Shares$346,200 Sold Last QuarterProj. Earnings Growth35.51%From $5.21 to $7.06 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.21 out of 5 starsMedical Sector340th out of 988 stocksSurgical & Medical Instruments Industry36th out of 101 stocks 2.3 Analyst's Opinion Consensus RatingICU Medical has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $195.00, ICU Medical has a forecasted upside of 20.7% from its current price of $161.51.Amount of Analyst CoverageICU Medical has received no research coverage in the past 90 days. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for ICUI. Previous Next 0.0 Dividend Strength Dividend YieldICU Medical does not currently pay a dividend.Dividend GrowthICU Medical does not have a long track record of dividend growth. Previous Next 3.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreICU Medical has received a 52.01% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Intravenous therapy equipment", "Catheters", and "Parenteral (intravenous) nutrition formulations" products. See details.Environmental SustainabilityThe Environmental Impact score for ICU Medical is -1.47. Previous Next 3.0 News and Social Media Coverage News SentimentICU Medical has a news sentiment score of 1.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.35 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for ICU Medical this week, compared to 2 articles on an average week.MarketBeat Follows3 people have added ICU Medical to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ICU Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $346,200.00 in company stock.Percentage Held by InsidersOnly 7.30% of the stock of ICU Medical is held by insiders.Percentage Held by Institutions93.88% of the stock of ICU Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for ICU Medical are expected to grow by 35.51% in the coming year, from $5.21 to $7.06 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of ICU Medical is -51.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of ICU Medical is -51.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioICU Medical has a P/B Ratio of 1.85. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About ICU Medical (NASDAQ:ICUI) StockICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.Read More Receive ICUI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ICU Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address ICUI Stock News HeadlinesMarch 10, 2023 | americanbankingnews.comICU Medical (NASDAQ:ICUI) Rating Increased to Hold at StockNews.comMarch 9, 2023 | finance.yahoo.comICU Medical to Participate at the KeyBanc Life Sciences & MedTech Investor ForumMarch 20, 2023 | Investor Place Media (Ad)The "King Of Quants" sees 10X potential...Eric Fry believes he just discovered America's next "Wealth Supercluster" and it's forming in the place you'd least expect. Investors are already flocking there for a chance at 1,000%+ returns. Here's how you could join them before it's too late...March 2, 2023 | msn.comICU Medical Earnings Perspective: Return On Capital EmployedMarch 1, 2023 | finance.yahoo.comICU Medical Full Year 2022 Earnings: Beats ExpectationsMarch 1, 2023 | seekingalpha.comICU Medical Not In Critical Condition, But There's Still Rehab Work To DoFebruary 28, 2023 | finance.yahoo.comQ4 2022 ICU Medical Inc Earnings CallFebruary 27, 2023 | finance.yahoo.comICU Medical Announces Fourth Quarter 2022 Results and Provides Fiscal Year 2023 GuidanceMarch 20, 2023 | Weiss Ratings (Ad)Banking NightmareDuring and after the Great Financial Crisis of 2008, 485 U.S. banks went under. Here at Weiss Ratings, we warned about 484 — an accuracy rate of 99.8%. Now, we have a new warning. But this time, it's not just about a few hundred banks … it's about nearly every single bank in America …February 27, 2023 | finance.yahoo.comICU Medical Announces Fourth Quarter 2022 Results and Provides Fiscal Year 2023 GuidanceFebruary 27, 2023 | finance.yahoo.comICU Medical (ICUI) Beats Q4 Earnings EstimatesFebruary 25, 2023 | thestreet.comICU Medical Stock Hits New 52-Week High (ICUI)February 24, 2023 | msn.comICU Medical's Earnings: A PreviewFebruary 21, 2023 | finance.yahoo.comICU Medical to Present at the Raymond James 44th Annual Institutional Investors ConferenceFebruary 15, 2023 | marketwatch.comICU Medical Equipment Market 2023 Segmented by Types, Application, Key Players and Regional Analysis to 2028February 13, 2023 | finance.yahoo.comICU Medical Announces Time of Fourth Quarter 2022 Earnings Conference CallFebruary 8, 2023 | finance.yahoo.comICU Medical's Plum 360™ Infusion System First-Ever to Receive Best in KLAS Honors as the Top-Performing Smart Pump in both EMR-Integrated and Traditional CategoriesJanuary 23, 2023 | finance.yahoo.comICU Medical (ICUI) Stock Jumps 5.8%: Will It Continue to Soar?January 16, 2023 | marketwatch.comNeonatal Critical Care Equipment Market Scope, Trends, Size, Share, Prominent Players and Forecast 2028January 13, 2023 | nasdaq.comICUI Makes Bullish Cross Above Critical Moving AverageJanuary 12, 2023 | nypost.comMount Sinai nurse details ICU chaos over strike: ‘We are dying up here’January 10, 2023 | forbes.comICU MedicalDecember 19, 2022 | finance.yahoo.comICU Medical to Present at the J.P. Morgan 41st Annual Healthcare ConferenceDecember 9, 2022 | seekingalpha.comICU Medical: Recent Breakout Piques Interest, But Lacks Supporting Market DataDecember 3, 2022 | nz.finance.yahoo.comAn Intrinsic Calculation For ICU Medical, Inc. (NASDAQ:ICUI) Suggests It's 22% UndervaluedNovember 8, 2022 | seekingalpha.comICU Medical, Inc. (ICUI) Q3 2022 Earnings Call TranscriptNovember 6, 2022 | finance.yahoo.comAs ICU Medical, Inc. (NASDAQ:ICUI) drops to US$3.3b market cap, insiders might rethink their US$4.5m stock purchase earlier this yearSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive ICUI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ICU Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address ICUI Company Calendar Last Earnings11/03/2021Today3/20/2023Next Earnings (Estimated)5/08/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Supplies SectorMedical Current SymbolNASDAQ:ICUI CUSIP44930G10 CIK883984 Webwww.icumed.com Phone(949) 366-2183Fax949-366-8368Employees14,500Year Founded1984Price Target and Rating Average Stock Price Forecast$195.00 High Stock Price Forecast$200.00 Low Stock Price Forecast$190.00 Forecasted Upside/Downside+21.1%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($3.12) Trailing P/E RatioN/A Forward P/E Ratio30.91 P/E GrowthN/ANet Income$-74,290,000.00 Net Margins-3.26% Pretax Margin-5.02% Return on Equity6.15% Return on Assets2.81% Debt Debt-to-Equity Ratio0.78 Current Ratio2.50 Quick Ratio1.09 Sales & Book Value Annual Sales$2.28 billion Price / Sales1.70 Cash Flow$16.83 per share Price / Cash Flow9.57 Book Value$87.15 per share Price / Book1.85Miscellaneous Outstanding Shares24,000,000Free Float22,246,000Market Cap$3.87 billion OptionableOptionable Beta0.61 Social Links Key ExecutivesVivek JainChairman & Chief Executive OfficerChristian B. VoigtlanderChief Operating OfficerBrian M. BonnellChief Financial Officer & TreasurerKrishna UppugonduriVP-Quality, Medical & Regulatory AffairsVirginia SanzoneSecretary, Vice President & General CounselKey CompetitorsHaemoneticsNYSE:HAEMerit Medical SystemsNASDAQ:MMSIAtrionNASDAQ:ATRIInari MedicalNASDAQ:NARIiRhythm TechnologiesNASDAQ:IRTCView All CompetitorsInsiders & InstitutionsVoya Investment Management LLCSold 119 shares on 2/28/2023Ownership: 0.015%Northwestern Mutual Wealth Management Co.Bought 11,030 shares on 2/21/2023Ownership: 0.455%Equitable Trust Co.Sold 393 shares on 2/21/2023Ownership: 0.013%Northwestern Mutual Investment Management Company LLCSold 1,035 shares on 2/21/2023Ownership: 0.008%Truist Financial CorpSold 599 shares on 2/17/2023Ownership: 0.008%View All Insider TransactionsView All Institutional Transactions ICUI Stock - Frequently Asked Questions Should I buy or sell ICU Medical stock right now? 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" ICUI shares. View ICUI analyst ratings or view top-rated stocks. What is ICU Medical's stock price forecast for 2023? 2 brokers have issued twelve-month target prices for ICU Medical's shares. Their ICUI share price forecasts range from $190.00 to $200.00. On average, they predict the company's stock price to reach $195.00 in the next twelve months. This suggests a possible upside of 21.1% from the stock's current price. View analysts price targets for ICUI or view top-rated stocks among Wall Street analysts. How have ICUI shares performed in 2023? ICU Medical's stock was trading at $157.48 at the start of the year. Since then, ICUI stock has increased by 2.3% and is now trading at $161.05. View the best growth stocks for 2023 here. When is ICU Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023. View our ICUI earnings forecast. How were ICU Medical's earnings last quarter? ICU Medical, Inc. (NASDAQ:ICUI) issued its quarterly earnings results on Wednesday, November, 3rd. The medical instruments supplier reported $2.07 earnings per share for the quarter, topping analysts' consensus estimates of $1.57 by $0.50. The medical instruments supplier had revenue of $336.06 million for the quarter, compared to the consensus estimate of $314.20 million. ICU Medical had a negative net margin of 3.26% and a positive trailing twelve-month return on equity of 6.15%. During the same quarter in the prior year, the firm posted $1.61 earnings per share. What ETFs hold ICU Medical's stock? ETFs with the largest weight of ICU Medical (NASDAQ:ICUI) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE), VanEck Morningstar SMID Moat ETF (SMOT), First Trust Health Care AlphaDEX Fund (FXH), FIS Knights of Columbus Global Belief ETF (KOCG), Invesco Nasdaq Future Gen 200 ETF (QQQS), Vanguard S&P Mid-Cap 400 Value ETF (IVOV), SPDR S&P 400 Mid Cap Value ETF (MDYV) and iShares S&P Mid-Cap 400 Value ETF (IJJ). What guidance has ICU Medical issued on next quarter's earnings? ICU Medical updated its FY 2023 earnings guidance on Monday, February, 27th. The company provided earnings per share guidance of $5.75-$7.25 for the period, compared to the consensus estimate of $1.29. The company issued revenue guidance of -. What is Vivek Jain's approval rating as ICU Medical's CEO? 81 employees have rated ICU Medical Chief Executive Officer Vivek Jain on Glassdoor.com. Vivek Jain has an approval rating of 73% among the company's employees. What other stocks do shareholders of ICU Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton, Dickinson and (BDX), BlackRock (BLK), NVIDIA (NVDA), Alibaba Group (BABA), CA (CA), UnitedHealth Group (UNH), Boeing (BA), Micron Technology (MU), Lockheed Martin (LMT) and ServiceNow (NOW). What is ICU Medical's stock symbol? ICU Medical trades on the NASDAQ under the ticker symbol "ICUI." Who are ICU Medical's major shareholders? ICU Medical's stock is owned by many different institutional and retail investors. Top institutional investors include T. Rowe Price Investment Management Inc. (10.10%), Nuance Investments LLC (3.92%), JPMorgan Chase & Co. (3.15%), Morgan Stanley (2.84%), Fuller & Thaler Asset Management Inc. (2.41%) and Neuberger Berman Group LLC (1.85%). Insiders that own company stock include Daniel Woolson, Elisha W Finney, George A Lopez, Robert S Swinney, Virginia Ruth Sanzone and Vivek Jain. View institutional ownership trends. How do I buy shares of ICU Medical? Shares of ICUI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is ICU Medical's stock price today? One share of ICUI stock can currently be purchased for approximately $161.05. How much money does ICU Medical make? ICU Medical (NASDAQ:ICUI) has a market capitalization of $3.87 billion and generates $2.28 billion in revenue each year. The medical instruments supplier earns $-74,290,000.00 in net income (profit) each year or ($3.12) on an earnings per share basis. How many employees does ICU Medical have? The company employs 14,500 workers across the globe. How can I contact ICU Medical? ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The official website for the company is www.icumed.com. The medical instruments supplier can be reached via phone at (949) 366-2183, via email at ir@icumed.com, or via fax at 949-366-8368. This page (NASDAQ:ICUI) was last updated on 3/20/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.